Search Press releases Keywords From To 21 Oct 2016 Transparency notification Read More 7 Oct 2016 Transparency notification Read More 3 Oct 2016 CIMZIA® (certolizumab pegol) Phase 3 Trial Meets Co-primary Efficacy Endpoints in Patients with Moderate-to-Severe Chronic Plaque Psoriasis Read More 26 Sep 2016 UCB and Amgen announce U.S. FDA acceptance of biologics licence application for Romosozumab Read More 26 Sep 2016 Transparency notification Read More 19 Sep 2016 UCB receives positive EU CHMP opinion for CIMZIA® (certolizumab pegol) AutoClicks® Prefilled Pen Read More Pagination First page Previous page Previous … Page 87 Page 88 Page 89 Page 90 Current page 91 Page 92 Page 93 Page 94 Page 95 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
